{"metadata": {"source": "erowid", "title": "Erowid MDMA Vault : MDMA FAQ", "description": "Frequently Asked Questions about MDMA", "language": "No language found.", "url": "https://www.erowid.org/chemicals/mdma/mdma_faq.shtml", "drug": "MDMA", "cid": 1615, "substance": "mdma", "category": "CHEMICALS", "erowid_column": "FAQ", "char_count": 37210, "word_count": 5516, "doc_id": "doc_187", "num_chunks": 56, "chunk_id": "187::chunk_28", "document_index": 187, "latency_s": 1.539128599994001, "prompt_toks": 8794, "completion_toks": 46, "relevance_score": 2.6274773e-05}, "content": "Drug: MDMA | cid: 1615\nSource: erowid | Source description: Frequently Asked Questions about MDMA\nErowid name: mdma\nCategory: CHEMICALS\nField: FAQ\n\n                    Text: \n                    III. Safety and Neurotoxicity Discussion\n\nBehavioral Safety Concerns\n\nAs noted, a primary psychological effect of MDMA is to make the user feel \"safe\", at peace with the world, pleasantly reconciled to things as they are, and things however they will be. This can remarkably diminish one's ability to make sound judgements during the session. Examples:\n\nIt becomes easy to want to prolong the MDMA state by taking more and more of the drug (or of other drugs), beyond what you would judge wise or worthwhile when not under its influence.\n\nIt becomes easier to have unsafe sex. You may \"forget,\" judge that the risk of infection is very small, or feel that infection wouldn't be such a terrible thing after all. If you think you might have sex while on MDMA, it may help you and your partner to stay safe if you lay out safer sex supplies before dosing in a place you'll be sure to see them later, and agree beforehand that you'll use them if the occasion arises.\n\n\n                    Context: \n                    This chunk provides an important overview of safety and neurotoxicity considerations related to MDMA use, emphasizing behavioral safety concerns such as impaired judgment, risk of unsafe sex, and the potential neurological and psychological effects discussed in the overall document.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 69, "doc_id": "doc_298", "num_chunks": 31, "chunk_id": "298::chunk_25", "document_index": 298, "latency_s": 0.8130401999951573, "prompt_toks": 4536, "completion_toks": 65, "relevance_score": 2.0785172e-05}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    and plots ) - These are more common within dark environments and can be comprehensively described through their variations as lucid in believability, interactive in style, new experiences in content, autonomous in controllability, geometry-based in style and almost exclusively of a personal, religious, spiritual, science-fiction, fantasy, surreal, nonsensical or transcendental nature in their overall theme.\n\n\n                    Context: \n                    This excerpt describes the characteristics of internal hallucinations (autonomous entities, settings, and scenarios) produced by psilocybin, emphasizing their prevalence in dark environments and their detailed, believable, and theme-specific nature, which is integral to understanding psilocybin's visual hallucination profile within the broader discussion of its effects.\n                "}
{"metadata": {"source": "erowid", "title": "Erowid Methamphetamines Vault : FAQ", "description": "Answers to frequently asked questions about Methamphetamine.", "language": "No language found.", "url": "https://www.erowid.org/chemicals/meth/meth_faq.shtml", "drug": "Methamphetamine", "cid": 10836, "substance": "meth", "category": "CHEMICALS", "erowid_column": "FAQ", "char_count": 49478, "word_count": 8104, "doc_id": "doc_193", "num_chunks": 69, "chunk_id": "193::chunk_15", "document_index": 193, "latency_s": 0.8927832000044873, "prompt_toks": 12187, "completion_toks": 67, "relevance_score": 1.8631747e-05}, "content": "Drug: Methamphetamine | cid: 10836\nSource: erowid | Source description: Answers to frequently asked questions about Methamphetamine.\nErowid name: meth\nCategory: CHEMICALS\nField: FAQ\n\n                    Text: \n                    Reducing condensation product of BMK and methylamine\n\nSynthesis from D-phenylalanine\n\nField Methods\n\nGeneral\n\nAdd a lot here on different methods.\n\nFrom: lamontg@u.washington.xxx (Lamont Granquist)\n\njkenner@cello.gina.calstate.edu (Jason Kennerly) writes: Manufacturing methamphetamine, on the other hand, requires the use of not just ether, but reducing agents such as LiAlH4. BAD STUFF! There are other recipes, but none to practical to attempt. Apartment manufacture of meth is not possible.\n\nReduction of ephedrine with HI is a little better than LAH reduction.\n\nCondensation Product of Phenylacetone and Methylamine\n\nFrom: ez026264@dale.ucdavis.edu (Speed Raver) Assuming you don't have amphetamine lying around, an easy synthesis with a very high yield is to reduce the condensation product of phenylacetone and methylamine. The benefit of this method is that different amines can be used to produce novel N-alkyl amphetamines (ethamphetamine, tert-butylamphetamine, etc.)\n\n\n                    Context: \n                    This section covers chemical synthesis routes for producing methamphetamine, including reduction of BMK and methylamine condensates, synthesis from D-phenylalanine, and field methods such as reducing phenylacetone with methylamine. It highlights practical methods, cautions, and alternative approaches relevant to clandestine manufacturing discussed throughout the document.\n                "}
